Back to Market Feed

DABIGATRAN ETEXILATE 110 MG CP

DABIGATRAN ETEXILATE
$0.9221per EA

Strength

110 mg/1

NDC

59651097460

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208039

On Market Since

5/14/2025

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-9.5%

3M

-27.4%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-34.4%

Generic Alternatives

1 alternative • Same active ingredient

DABIGATRAN ETEXILATE 110 MG CP
Generic
72205020360•Novadoz Pharmaceuticals LLC
$0.9221

Related Drugs

Same classification

DABIGATRAN ETEXILATE 75 MG CAP
Generic
00378026591•Mylan Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
00904725304•Major Pharmaceuticals
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
00904725368•Major Pharmaceuticals
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
31722062132•Camber Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
31722062160•Camber Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
43598064260•Dr. Reddy's Laboratories Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
60505434706•Apotex Corp.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
62332063406•Alembic Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
62332063460•Alembic Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
67877047460•Ascend Laboratories, LLC
$0.8478
per EA